07:29 PM • Dalla Lana School of Public HealthReporting, epidemic growth, and reproduction numbers for the 2019-nCoV epidemic: understanding control

06:51 PM • NatureMore than 80 clinical trials launch to test coronavirus treatments

06:47 PM • STATOnce widely criticized, the Wuhan quarantine bought the world time to prepare for Covid-19


04:52 PM • Genetic Engineering & Biotechnology NewsBase Editing Promise in Treating a Mouse Model of Progeria

04:48 PM • Nature BiotechnologyEvaluation and minimization of Cas9-independent off-target DNA editing by cytosine base editors

04:42 PM • NatureSuper-precise CRISPR tool enhanced by enzyme engineering

04:33 PM • The Harvard GazetteA crisper CRISPR

03:52 PM • New England Journal of Medicine (NEJM)Milk and Health

03:45 PM • Elemental-a Medium publicationTime to Question Everything You Know About Milk


06:06 PM • Genetic Engineering & Biotechnology NewsMERS Coronavirus Disease Blocked by Remdesivir in Monkeys

05:55 PM • The Motley FoolReport: Gilead Struggling to Find Subjects for COVID-19 Drug Trial

05:53 PM • ClinicalTrials.govSevere 2019-nCoV Remdesivir RCT

05:51 PM • ClinicalTrials.govSevere 2019-nCoV Remdesivir RCT

05:48 PM • BioSpaceGilead Struggles to Recruit Patients for Coronavirus Drug Trial in China

05:41 PM • Wall Street JournalGilead’s Coronavirus Drug Trial Slowed by Lack of Eligible Recruits


04:45 PM • ScienceTreg cells—the next frontier of cell therapy

04:42 PM • STATJeffrey Bluestone steps down as Parker Institute president to develop cell therapies for autoimmune diseases

04:39 PM • Endpoints NewsJeffrey Bluestone exits Parker and switches focus back to autoimmune diseases in cell therapy 2.0 launch

04:35 PM • BioSpaceParker Institute CEO Jeffrey Bluestone Steps Down to Launch Sonoma Biotherapeutics

03:09 PM • The Harvard GazetteCollaboration generates most complete cancer genome map

02:56 AM • International Cancer Genome Consortium - ICGCPCAWG - PANCANCER ANALYSIS OF WHOLE GENOMES

02:54 AM • NatureThe era of massive cancer sequencing projects has reached a turning point

02:52 AM • ScienceMassive cancer genome study reveals how DNA errors drive tumor growth


09:53 PM • Financial TimesBiogen shares soar after patent victory

09:37 PM • STATBiogen wins patent challenge to key multiple sclerosis drug

08:00 PM • Fortune MagazineChina wants to patent Gilead’s promising coronavirus treatment

07:55 PM • TIME (US magazine)China Applies for Patent for Drug That Could Fight Coronavirus

07:49 PM • ClinicalTrials.govMild/Moderate 2019-nCoV Remdesivir RCT

07:46 PM • The VergeAn experimental antiviral medication might help fight the new coronavirus

07:39 PM • New England Journal of Medicine (NEJM)First Case of 2019 Novel Coronavirus in the United States

07:37 PM • Seeking AlphaTesting of Gilead's remdesivir in coronavirus patients to start tomorrow in China

04:27 PM • Fortune MagazineThe Gates Foundation is pledging up to $100 million for the fight against coronavirus

02:54 PM • Bill & Melinda Gates FoundationBill & Melinda Gates Foundation Dedicates Additional Funding to the Novel Coronavirus Response

01:42 PM • Wall Street JournalMerck to Spin Off Slow-Growth Products Into New Company

01:37 PM • Financial TimesGSK outlines plan to split as earnings fall short

01:35 PM • Seeking AlphaMerck to sharpen focus on key growth drivers via spinout of non-core units


09:14 PM • New England Journal of Medicine (NEJM)Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany

09:13 PM • STATHigh-profile report on asymptomatic spread of coronavirus based on faulty information, health officials say

09:01 PM • ScienceStudy claiming new coronavirus can be transmitted by people without symptoms was flawed


10:28 PM • CNBCTrump imposes travel restrictions, mandatory quarantines over coronavirus outbreak


08:09 PM • MarketWatchCoronavirus update: First U.S. case of person-to-person transmission confirmed, 195 U.S. citizens in isolation and WHO declares a public health emergency

08:03 PM • BBCCoronavirus declared global health emergency by WHO


08:16 PM • STATWHO praises China’s response to coronavirus, will reconvene expert committee to assess global threat


08:13 PM • NBCCoronavirus risk in U.S. 'remains low' even as federal officials take steps to protect public

08:10 PM • CNBCUS health officials fast-track coronavirus vaccine, hope to start clinical trial in three months

08:08 PM • New York TimesCoronavirus Live Updates: Cases Up Nearly 60%, as Airports Expand Screenings


03:51 PM • University of QueenslandUQ responds to coronavirus pandemic

03:41 PM • Moderna TherapeuticsModerna Announces Funding Award from CEPI to Accelerate Development of Messenger RNA (mRNA) Vaccine Against Novel Coronavirus

03:29 PM • Inovio Pharmaceuticals, Inc.Inovio Selected by CEPI to Develop Vaccine Against New Coronavirus

03:19 PM • CEPI-Coalition for Epidemic PreparednessInnovationCEPI to fund three programmes to develop vaccines against the novel coronavirus, nCoV-2019